List of DNAnexus Platform Customers
DNAnexus
1975 W El Camino, Suite 101,
Mountain View, 94040, CA,
United States
Mountain View, 94040, CA,
United States
1 415-857-0158
Professional Services
290
$32M
Since 2010, our global team of researchers has been studying DNAnexus Platform customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased DNAnexus Platform for Analytics and BI from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using DNAnexus Platform for Analytics and BI include: AstraZeneca, a United Kingdom based Life Sciences organisation with 94300 employees and revenues of $73.98 billion, City of Hope, a United States based Healthcare organisation with 10000 employees and revenues of $4.16 billion, UK Biobank, a United Kingdom based Professional Services organisation with 412 employees and revenues of $43.0 million and many others.
Contact us if you need a completed and verified list of companies using DNAnexus Platform, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The DNAnexus Platform customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
AstraZeneca | Life Sciences | 94300 | $74.0B | United Kingdom | DNAnexus | DNAnexus Platform | Analytics and BI | 2017 | n/a |
In 2017, AstraZeneca selected the DNAnexus Platform to support its Centre for Genomics Research, deploying an Analytics and BI capability for large scale genomic data management and analysis. The engagement targeted analysis of millions of genomes and explicit integration of genomic data with clinical trial data to accelerate target identification and biomarker discovery for drug discovery and R and D across the United Kingdom and global research sites.
The DNAnexus Platform implementation focused on large scale genomics and translational informatics modules, including sequence data management, scalable compute pipelines for variant analysis, cohort analytics, and tools for cross modality data harmonization. Configuration emphasized data provenance, secure access controls, and pipeline orchestration to support reproducible analytical workflows at cohort scale.
Deployment used a cloud oriented architecture to provide elastic compute and secure long term storage for genomic datasets, enabling distributed researcher access from AstraZeneca sites in the United Kingdom and internationally. The platform was integrated with AstraZeneca clinical trial datasets and internal R and D data stores to enable joint genomic and phenotypic analysis, relying on APIs and standardized data exchange workflows for interoperability.
Governance and operationalization centered on establishing controlled researcher access, standardized analytic pipelines, and data curation practices to manage consented genomic cohorts and clinical linkages. The collaboration was structured as a sustained research program between AstraZeneca and DNAnexus, operationalizing translational informatics within the Centre for Genomics Research and aligning analytic workflows to drug discovery and R and D use cases.
|
 |
City of Hope | Healthcare | 10000 | $4.2B | United States | DNAnexus | DNAnexus Platform | Analytics and BI | 2020 | n/a |
In 2020 City of Hope partnered with DNAnexus to implement the DNAnexus Platform and build POSEIDON, a precision oncology environment that harmonizes de-identified clinico-genomic and multi-omics data to support research and clinical decision-making in the United States. The DNAnexus Platform is positioned in the Analytics and BI category to enable cross-modal data aggregation and cohort level analytics for oncology research and clinical workflows.
The implementation centered on modules and capabilities for cohort discovery, clinical trial matching and tumor-board decision support, with inferred multi-omics and cohort analytics pipelines configured on DNAnexus technologies. Data ingestion and harmonization workflows were implemented to standardize de-identified clinical and genomic inputs, and analytics pipelines were instrumented to surface cohort filters and evidence layers used by tumor boards.
Architecturally the deployment leverages DNAnexus technologies as a shared data and compute platform, with project level workspaces and secure de-identified data stores to enable collaboration across research teams. Operational coverage emphasizes research and clinical decision support within City of Hope in the United States, providing a centralized analytics environment for investigators and clinicians.
Governance practices were incorporated to maintain de-identification, role based access controls and standardized data models to support controlled sharing, cohort discovery and clinical trial matching workflows. The implementation explicitly improves data access and collaboration across research teams and embeds the DNAnexus Platform in City of Hope workflows for precision oncology research and tumor-board decision support.
|
 |
UK Biobank | Professional Services | 412 | $43M | United Kingdom | DNAnexus | DNAnexus Platform | Analytics and BI | 2021 | n/a |
In 2021, UK Biobank launched the DNAnexus Platform as the UK Biobank Research Analysis Platform to provide approved researchers with global, secure cloud access to petabyte scale genomic, imaging and phenotypic data held in the United Kingdom. The DNAnexus Platform is delivered as an Analytics and BI capability for cohort discovery and large scale analysis, aligning UK Biobank DNAnexus Platform Analytics and BI to population genomics and biomedical research workflows.
The implementation centralized multi petabyte data storage, cataloging and controlled researcher workspaces, and provisioned analysis pipelines and cohort building tooling consistent with Analytics and BI deployments. Access governance was built into the platform to enforce approved researcher onboarding, controlled access to sensitive datasets and audit logging, while compute and workflow orchestration provided repeatable analysis environments.
UK Biobank partnered with DNAnexus and AWS to combine DNAnexus Platform software with cloud storage and compute infrastructure, enabling a cloud native architecture that scaled to tens of petabytes. Governance and operational controls focused on approved researcher access and data use policy enforcement within the United Kingdom. Outcomes reported at launch included democratized access to large scale datasets and accelerated cohort building and analysis for population genomics and biomedical research worldwide.
|
Showing 1 to 3 of 3 entries
Buyer Intent: Companies Evaluating DNAnexus Platform
ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating DNAnexus Platform. Gain ongoing access to real-time prospects and uncover hidden opportunities.
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||
FAQ - APPS RUN THE WORLD DNAnexus Platform Coverage
DNAnexus Platform is a Analytics and BI solution from DNAnexus.
Companies worldwide use DNAnexus Platform, from small firms to large enterprises across 21+ industries.
Organizations such as AstraZeneca, City of Hope and UK Biobank are recorded users of
DNAnexus Platform for Analytics and BI.
Companies using DNAnexus Platform are most concentrated in Life Sciences, Healthcare and Professional Services, with adoption spanning over 21 industries.
Companies using DNAnexus Platform are most concentrated in United Kingdom and United States, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of DNAnexus Platform across Americas, EMEA, and APAC.
Companies using DNAnexus Platform range from small businesses with 0-100 employees - 0%, to mid-sized firms with 101-1,000 employees - 33.33%, large organizations with 1,001-10,000 employees - 33.33%, and global enterprises with 10,000+ employees - 33.33%.
Customers of DNAnexus Platform include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.
Contact APPS RUN THE WORLD to access the full verified DNAnexus Platform customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Analytics and BI.